Daré Bioscience, Inc.
DARE
$1.75
$0.031.45%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.08M | 5.04M | 10.33M | 15.70M | 11.23M |
| Total Receivables | 369.20K | 188.10K | 105.20K | 230.00K | 518.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.51M | 1.38M | 1.39M | 2.52M | 3.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 53.20K | -- | -- | -- | -- |
| Total Current Assets | 25.00M | 6.60M | 11.82M | 18.45M | 14.95M |
|
|
|||||
| Total Current Assets | 25.00M | 6.60M | 11.82M | 18.45M | 14.95M |
| Net Property, Plant & Equipment | 4.73M | 5.31M | 5.72M | 2.54M | 2.03M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.02M | 1.07M | 1.08M | 1.11M | 1.08M |
| Total Assets | 30.75M | 12.98M | 18.62M | 22.10M | 18.06M |
|
|
|||||
| Total Accounts Payable | 1.84M | 1.76M | 1.88M | 1.46M | 1.05M |
| Total Accrued Expenses | 2.32M | 2.52M | 1.77M | 3.04M | 1.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.48M | 2.42M | 2.32M | 548.60K | 505.80K |
| Total Finance Division Other Current Liabilities | 14.57M | 12.51M | 15.21M | 16.56M | 9.75M |
| Total Other Current Liabilities | 14.57M | 12.51M | 15.21M | 16.56M | 9.75M |
| Total Current Liabilities | 21.22M | 19.22M | 21.19M | 21.61M | 13.16M |
|
|
|||||
| Total Current Liabilities | 21.22M | 19.22M | 21.19M | 21.61M | 13.16M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 453.80K | 612.60K | 1.25M | 754.40K | 897.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.22M | 5.88M | 5.74M | 5.75M | 5.49M |
| Total Liabilities | 27.89M | 25.71M | 28.18M | 28.11M | 19.54M |
|
|
|||||
| Common Stock & APIC | 190.50M | 171.35M | 170.52M | 169.71M | 168.66M |
| Retained Earnings | -187.25M | -183.68M | -179.67M | -175.29M | -169.78M |
| Treasury Stock & Other | -396.00K | -402.80K | -415.70K | -428.80K | -362.60K |
| Total Common Equity | 2.86M | -12.73M | -9.56M | -6.01M | -1.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.86M | -12.73M | -9.56M | -6.01M | -1.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.86M | -12.73M | -9.56M | -6.01M | -1.48M |
|
|
|||||